image
image
user-login
Patent search/

AN ASTHMA INHALATION MONITORING DEVICE FOR IMPROVED SYMPTOM MANAGEMENT

search

Patent Search in India

  • tick

    Extensive patent search conducted by a registered patent agent

  • tick

    Patent search done by experts in under 48hrs

₹999

₹399

Talk to expert

AN ASTHMA INHALATION MONITORING DEVICE FOR IMPROVED SYMPTOM MANAGEMENT

ORDINARY APPLICATION

Published

date

Filed on 16 November 2024

Abstract

The present invention discloses an asthma inhalation monitoring device (100) designed to improve asthma management by integrating advanced components. The device includes an inhalation flow sensor (10) for accurate medication delivery, a feedback mechanism (20) providing real-time cues, an environmental monitoring system (30) for detecting triggers, a communication module (40) for IoT connectivity, and a usage tracking system (50) for adherence monitoring. Its compact design and smartphone integration enhance patient education, self-management, and collaboration with healthcare providers, reducing asthma-related complications.

Patent Information

Application ID202411088808
Invention FieldBIO-MEDICAL ENGINEERING
Date of Application16/11/2024
Publication Number48/2024

Inventors

NameAddressCountryNationality
Dr. SANKET JHEETAYDepartment of Physiology, Graphic Era Institute of Medical Sciences, Graphic Era deemed to be University, Dehradun.IndiaIndia
Dr. JANHVI MISHRA RAWATDepartment of Biotechnology, Graphic Era deemed to be University, Dehradun.IndiaIndia

Applicants

NameAddressCountryNationality
GRAPHIC ERA DEEMED TO BE UNIVERSITY566/6, Bell Road, Society Area, Clement Town, Dehradun – 248002, Uttarakhand, India.IndiaIndia

Specification

Description:FIELD OF THE INVENTION:
The field of the invention relates to respiratory healthcare devices, specifically to asthma management technologies. It focuses on improving symptom management through real-time inhalation monitoring, usage tracking, and environmental trigger detection, ensuring better adherence to treatment plans and reducing asthma-related complications.

BACKGROUD OF THE INVENTION:
Background description includes information that may be useful in understanding the present invention. It is not an admission that any of the information provided herein is prior art or relevant to the presently claimed invention, or that any publication specifically or implicitly referenced is prior art.
Asthma is a chronic respiratory condition that affects millions of individuals worldwide, leading to significant health challenges and an increased burden on healthcare systems. Characterized by episodes of airway inflammation, bronchoconstriction, and excessive mucus production, asthma can cause difficulty breathing, wheezing, and coughing. Effective management of the condition is crucial to improve the quality of life for patients and reduce the risk of severe exacerbations that may require hospitalization. Despite the availability of advanced treatments, adherence to asthma management plans remains a critical issue, often due to improper inhaler usage, lack of awareness, and environmental triggers.
Inhalers are the primary method for delivering medication directly to the lungs, providing immediate relief and long-term control of asthma symptoms. However, studies have shown that a large percentage of asthma patients misuse inhalers, failing to achieve the intended therapeutic effect. Incorrect inhaler technique, such as inadequate inhalation speed, incomplete medication delivery, or skipping doses, can significantly compromise treatment efficacy. This is further compounded by the absence of a real-time feedback mechanism to guide patients during inhaler use, leaving healthcare providers with incomplete information about adherence and symptom control.
Another challenge in asthma management is the unpredictability of environmental triggers, such as pollen, dust, smoke, and changes in humidity, which can exacerbate symptoms. Many patients are unaware of these external factors and their impact on asthma control, leading to sudden and potentially life-threatening exacerbations. The need for a comprehensive solution that not only monitors inhaler usage but also accounts for environmental variables is evident.
Advancements in technology, particularly in the fields of sensors, Internet of Things (IoT), and artificial intelligence, offer an opportunity to address these challenges. Integrating these technologies into a compact, user-friendly device could revolutionize asthma management by providing real-time data and actionable insights to both patients and healthcare providers. Such a solution would bridge the gap between medication adherence and symptom monitoring, ensuring better control of the condition and reducing the frequency of asthma-related complications.
Existing devices and apps designed for asthma management are often limited in functionality, focusing solely on reminders or dose tracking. While these features are helpful, they fail to address critical aspects such as real-time inhalation monitoring, feedback on technique, and environmental trigger detection. Moreover, many of these solutions require manual input from users, making them less reliable and prone to errors. A fully automated device that eliminates the need for user intervention and provides seamless integration with healthcare systems would significantly improve patient outcomes.
The envisioned invention combines multiple functionalities into a single device that attaches to an inhaler, enabling comprehensive monitoring of asthma management. Equipped with advanced sensors, the device detects inhalation flow rate and volume, ensuring that the medication is delivered correctly. This information is instantly analyzed, and feedback is provided to the user through visual or audio cues, helping them adjust their technique if necessary. By recording each use, the device creates a detailed log of medication adherence, which can be shared with healthcare providers during follow-up visits.
In addition to monitoring inhaler usage, the device incorporates environmental sensors to detect triggers such as pollen levels, air quality, and humidity. This data is transmitted to a smartphone app, allowing users to make informed decisions about their activities and surroundings. For instance, the app could recommend avoiding outdoor activities on days with high pollen counts or poor air quality, thereby preventing exacerbations. This proactive approach empowers patients to take control of their asthma, reducing reliance on emergency interventions.
The integration of IoT technology enables seamless connectivity between the device, smartphone apps, and healthcare systems. Patients can receive personalized reminders for medication use, symptom tracking prompts, and alerts about environmental triggers directly on their smartphones. Healthcare providers can access this data remotely, gaining valuable insights into the patient's adherence and symptom trends. This facilitates more informed decision-making and enables timely adjustments to treatment plans, ultimately improving patient outcomes.
Another significant benefit of the invention is its potential to enhance patient education and awareness. By providing real-time feedback on inhaler technique and highlighting the impact of environmental factors, the device helps patients understand the importance of proper management. This not only improves adherence but also reduces anxiety and fear associated with asthma attacks. Over time, patients become more confident in managing their condition, leading to better long-term control.
The compact and lightweight design of the device ensures that it does not add significant bulk to the inhaler, making it convenient for daily use. The device is also designed to be compatible with various types of inhalers, ensuring accessibility for a wide range of patients. Its user-friendly interface and intuitive app make it suitable for individuals of all ages, including children and the elderly, who may have difficulty understanding complex instructions.
Therefore, asthma remains a challenging condition to manage due to issues such as improper inhaler usage, poor adherence, and the influence of environmental triggers. While existing solutions address some of these challenges, they fall short of providing a comprehensive approach. The proposed invention leverages advanced technology to fill this gap, offering a device that monitors inhaler usage, detects environmental triggers, and provides real-time feedback and insights. By empowering patients and healthcare providers with accurate and actionable data, the invention has the potential to transform asthma management and significantly improve patient outcomes.

OBJECTS OF THE INVENTION:
The prime object of the invention is to provide an asthma inhalation monitoring device that ensures accurate tracking of inhaler usage and delivers real-time feedback on inhalation technique, enabling effective symptom management for asthma patients.
Another object of the invention is to integrate advanced sensors into the device to monitor the flow rate and volume of inhaler medication intake, thereby ensuring proper delivery and reducing the risk of improper usage, which is a common issue among asthma patients.
Yet another object of the invention is to provide a device that includes environmental monitoring capabilities, such as the detection of air quality, pollen levels, and humidity, allowing users to proactively manage environmental triggers that may exacerbate asthma symptoms.
Still another object of the invention is to offer seamless connectivity through IoT technology, enabling real-time data sharing between the device, a smartphone application, and healthcare providers. This connectivity facilitates better adherence tracking and allows for timely intervention based on the patient's usage patterns and symptom trends.
A further object of the invention is to provide an easy-to-use and compact device that is compatible with various inhaler types, ensuring accessibility for patients of all ages and physical capabilities without adding significant bulk to their inhalers.
An additional object of the invention is to enhance patient education by providing visual and audio feedback on inhaler technique, as well as alerts and reminders for medication usage and environmental risks, thereby empowering patients to take a more active role in managing their condition.
Yet a further object of the invention is to support healthcare providers with comprehensive and accurate data on patient adherence and symptom management, enabling more informed decision-making and personalized treatment plans during follow-up consultations.
Finally, an object of the invention is to reduce the frequency and severity of asthma exacerbations by providing a proactive approach to asthma management, combining medication adherence, environmental awareness, and real-time feedback to improve overall patient outcomes.

SUMMARY OF THE INVENTION:
The present invention provides an innovative asthma inhalation monitoring device designed to improve symptom management and adherence to treatment plans. The device integrates advanced technologies, including inhalation flow sensors, IoT connectivity, and environmental monitoring, to offer a comprehensive solution for asthma management. It empowers patients and healthcare providers with real-time feedback, actionable insights, and data-driven decision-making capabilities, ultimately enhancing the quality of life for asthma patients.
An inventive aspect of the invention is to provide a device equipped with inhalation flow sensors that monitor the flow rate and volume of inhaler medication during each use. This ensures proper medication delivery, minimizes the risk of ineffective treatment due to incorrect inhaler techniques, and enhances the therapeutic outcomes for asthma patients.
Another inventive aspect of the invention is to provide real-time feedback mechanisms, such as audio or visual alerts, that guide patients in adjusting their inhalation technique during inhaler use. This feature significantly reduces the likelihood of misuse and helps patients build confidence in managing their asthma effectively.
Yet another inventive aspect of the invention is to incorporate environmental monitoring capabilities within the device. Sensors for detecting pollen levels, air quality, temperature, and humidity enable patients to identify and avoid environmental triggers that could exacerbate their asthma symptoms, promoting a proactive approach to symptom prevention.
Still another inventive aspect of the invention is to enable seamless connectivity through IoT technology, allowing the device to sync with a dedicated smartphone application. This integration facilitates data sharing with healthcare providers, personalized reminders for medication use, and alerts about environmental risks, thereby creating a connected ecosystem for asthma management.
A further inventive aspect of the invention is to provide compatibility with various types of inhalers, ensuring its applicability across a wide patient demographic. The compact and lightweight design of the device ensures convenience and ease of use, making it suitable for daily application without adding bulk to the inhaler.
Yet a further inventive aspect of the invention is to include a comprehensive adherence tracking system. The device records the frequency and timing of inhaler usage, creating a detailed log that can be accessed by healthcare providers to assess patient compliance and adjust treatment plans as needed.
An additional inventive aspect of the invention is to enhance patient education and awareness through the smartphone application, which provides insights into inhaler usage, environmental triggers, and asthma management tips. This feature empowers patients to take an active role in managing their condition, improving long-term adherence and reducing anxiety related to asthma attacks.
Finally, an inventive aspect of the invention is to integrate a preventive framework for asthma exacerbations by combining medication adherence, real-time feedback, and environmental awareness. This holistic approach ensures that patients are well-prepared to manage their condition effectively, leading to better health outcomes and a reduced need for emergency medical interventions.

BRIEF DESCRIPTION OF DRAWINGS:
The accompanying drawings illustrate various embodiments of "An Asthma Inhalation Monitoring Device for Improved Symptom Management," highlighting key aspects of its design and functionality. These figures are intended for illustrative purposes to aid in understanding the invention and are not meant to limit its scope.
FIG. 1 depicts a block diagram of an asthma inhalation monitoring device, showing its components and connectivity, according to an embodiment of the present invention.
The drawings provided will be further described in detail in the following sections. They offer a visual representation of the asthma inhalation monitoring device's structure, operational features, and integration with external systems, helping to clarify and support the detailed description of the invention.

DETAILED DESCRIPTION OF THE INVENTION:
In the following detailed description, reference is made to the accompanying drawings which form a part hereof, and in which is shown by way of illustration specific embodiments in which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is to be understood that the embodiments may be combined, or that other embodiments may be utilized and that structural and logical changes may be made without departing from the spirit and scope of the present invention. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims and their equivalents.
The present invention is described in brief with reference to the accompanying drawings. Now, refer in more detail to the exemplary drawings for the purposes of illustrating non-limiting embodiments of the present invention.
As used herein, the term "comprising" and its derivatives including "comprises" and "comprise" include each of the stated integers or elements but does not exclude the inclusion of one or more further integers or elements.
As used herein, the singular forms "a", "an", and "the" include plural referents unless the context clearly dictates otherwise. For example, reference to "a device" encompasses a single device as well as two or more devices, and the like.
As used herein, the terms "for example", "like", "such as", or "including" are meant to introduce examples that further clarify more general subject matter. Unless otherwise specified, these examples are provided only as an aid for understanding the applications illustrated in the present disclosure, and are not meant to be limiting in any fashion.
As used herein, the terms ""may", "can", "could", or "might" be included or have a characteristic, that particular component or feature is not required to be included or have the characteristic.
Exemplary embodiments will now be described more fully hereinafter with reference to the accompanying drawings, in which exemplary embodiments are shown. These exemplary embodiments are provided only for illustrative purposes and so that this disclosure will be thorough and complete and will fully convey the scope of the invention to those of ordinary skill in the art. The invention disclosed may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein.
Various modifications will be readily apparent to persons skilled in the art. The general principles defined herein may be applied to other embodiments and applications without departing from the spirit and scope of the invention. Moreover, all statements herein reciting embodiments of the invention, as well as specific examples thereof, are intended to encompass both structural and functional equivalents thereof. Additionally, it is intended that such equivalents include both currently known equivalents as well as equivalents developed in the future (i.e., any elements developed that perform the same function, regardless of structure). Also, the terminology and phraseology used is for the purpose of describing exemplary embodiments and should not be considered limiting. Thus, the present invention is to be accorded the widest scope encompassing numerous alternatives, modifications and equivalents consistent with the principles and features disclosed. For purpose of clarity, details relating to technical material that is known in the technical fields related to the invention have not been described in detail so as not to unnecessarily obscure the present invention.
Each of the appended claims defines a separate invention, which for infringement purposes is recognized as including equivalents to the various elements or limitations specified in the claims. Depending on the context, all references below to the "invention" may in some cases refer to certain specific embodiments only. In other cases, it will be recognized that references to the "invention" will refer to subject matter recited in one or more, but not necessarily all, of the claims.
All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., "such as") provided with respect to certain embodiments herein is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention otherwise claimed. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the invention.
Various terms as used herein are shown below. To the extent a term used in a claim is not defined below, it should be given the broadest definition and persons in the pertinent art have given that term as reflected in printed publications and issued patents at the time of filing.
Groupings of alternative elements or embodiments of the invention disclosed herein are not to be construed as limitations. Each group member can be referred to and claimed individually or in any combination with other members of the group or other elements found herein. One or more members of a group can be included in, or deleted from, a group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is herein deemed to contain the group as modified thus fulfilling the written description of all groups used in the appended claims.
With reference to FIG. 1,
The invention relates to a device for asthma inhalation monitoring (100) designed to improve the management of asthma by ensuring proper inhaler usage and providing comprehensive data for patients and healthcare providers. The device incorporates a series of innovative features to address the common challenges associated with asthma management, including improper inhaler techniques, poor medication adherence, and the influence of environmental triggers.
At the core of the device is an inhalation flow sensor (10), which is configured to detect the flow rate and volume of medication intake during inhaler usage. This sensor plays a critical role in monitoring the inhalation process, providing precise measurements to ensure that the medication is delivered correctly to the patient's lungs. Incorrect inhaler techniques, such as inhaling too quickly or slowly, can significantly reduce the effectiveness of asthma treatment. The inclusion of this sensor ensures that these issues are identified and corrected in real-time, allowing for optimal therapeutic outcomes.
To assist the user in achieving proper inhalation technique, the device features a feedback mechanism (20) that provides real-time cues. These cues can be visual, such as LED indicators, or audio, such as beeps or voice prompts, guiding the user to adjust their inhalation speed or duration. For example, if the inhalation flow rate is too high or too low, the feedback mechanism alerts the user immediately, allowing them to modify their technique during the same usage session. This feature significantly reduces the likelihood of improper usage, which is a leading cause of treatment failure in asthma management.
Another critical component of the device is the environmental monitoring system (30), which is equipped with sensors to detect air quality, pollen levels, humidity, and temperature. Environmental factors are known to exacerbate asthma symptoms and trigger attacks in sensitive individuals. By continuously monitoring these variables, the device can provide timely alerts to the user about potential risks in their surroundings. For instance, if pollen levels are high, the device can recommend limiting outdoor activities or taking additional preventive measures. This proactive approach helps users manage their condition more effectively, reducing the frequency of exacerbations.
The communication module (40) enables seamless data transfer between the device and a smartphone application. Using IoT connectivity, such as Bluetooth or Wi-Fi, the module ensures that all usage and environmental data are transmitted to the app in real time. This connectivity allows patients to access detailed logs of their inhaler usage, environmental exposure, and adherence trends. Furthermore, healthcare providers can remotely review this data to assess the patient's adherence to their treatment plan and make informed decisions about potential adjustments to their medication or management strategies.
A key feature of the invention is the usage tracking system (50), which records the time, date, and frequency of inhaler usage. This system helps ensure adherence by maintaining an accurate log of how often and when the inhaler is used. Non-adherence to prescribed medication regimens is a common issue in asthma management, often resulting in poor symptom control and increased healthcare costs. By tracking usage data, the device provides insights into the patient's adherence patterns, allowing both the patient and their healthcare provider to identify and address any gaps in their treatment routine.
The device is further enhanced by its integration with a smartphone application, which serves as a central hub for displaying all collected data. The app provides usage logs, environmental risk alerts, and adherence reports, offering a comprehensive view of the patient's asthma management. This integration also enables personalized notifications and reminders for scheduled inhaler usage or potential environmental risks, ensuring that the patient remains proactive in managing their condition. Real-time analytics and trend reports generated by the app further enhance patient education and self-management, empowering users to take control of their health.
The compact and lightweight design of the device ensures portability and ease of use. It is designed to attach seamlessly to a wide range of inhaler models without obstructing their functionality or adding significant bulk. This compatibility ensures that the device is accessible to a diverse patient population, including children and the elderly, who may have different inhaler requirements. The intuitive interface and user-friendly design make the device suitable for individuals with varying levels of technological proficiency, further broadening its accessibility.
The device also incorporates a memory module within the usage tracking system (50) to store historical data on medication adherence. This feature allows for the long-term analysis of adherence patterns, providing valuable insights into the effectiveness of the treatment plan. Additionally, the stored data can be used to generate detailed adherence reports for review by healthcare providers during follow-up visits, facilitating more informed and personalized care.
One of the notable features of the device is its ability to provide reminders and notifications to the user. These reminders are designed to ensure that the patient remains consistent with their inhaler usage schedule, addressing one of the most common challenges in asthma management. Notifications about potential environmental risks, such as high pollen levels or poor air quality, further enhance the user's ability to manage their condition proactively.
The device's ability to provide real-time analytics and trend reports through the smartphone application is another significant innovation. By analyzing inhaler usage data and environmental exposure trends, the app can generate actionable insights for the patient. For example, it may identify patterns indicating that certain environmental factors consistently exacerbate the patient's symptoms, allowing them to take preventive measures in similar conditions. These analytics not only improve patient education but also foster a deeper understanding of their condition, leading to better long-term management.
To ensure continuous operation and reliability, the device is powered by an energy-efficient power source. This feature supports extended periods of monitoring and operation, reducing the need for frequent recharging and enhancing the user's experience. The device's durable construction and high-quality components further ensure its longevity and reliability in various usage scenarios.
Therefore, the invention provides a comprehensive solution for asthma management, addressing critical challenges such as improper inhaler techniques, poor adherence, and environmental triggers. By integrating advanced sensors, IoT connectivity, and real-time feedback mechanisms, the device empowers patients and healthcare providers with the tools they need to manage asthma effectively. Its user-friendly design, compatibility with various inhaler models, and integration with a smartphone application make it a versatile and accessible tool for individuals with asthma. Through its innovative features and functionalities, the device has the potential to significantly improve patient outcomes, reduce the frequency of exacerbations, and enhance the overall quality of life for individuals living with asthma.

Working of the invention: The asthma inhalation monitoring device functions as a comprehensive solution for managing asthma by integrating advanced technologies into a single, user-friendly system. When the patient uses the inhaler, the device automatically activates to monitor the process, provide feedback, and record essential data without requiring manual intervention. At its core, the device includes an inhalation flow sensor that detects the flow rate and volume of medication during usage. This sensor plays a critical role in ensuring that the medication is delivered effectively to the lungs. By analyzing the inhalation parameters in real time, the sensor identifies any deviations from the optimal range, such as inhaling too quickly or too slowly, which could compromise treatment efficacy.
Once the inhalation flow sensor captures the data, it communicates with the feedback mechanism embedded within the device. The feedback mechanism provides immediate cues to the user, either through visual indicators, such as LEDs, or audio alerts. If the inhalation is too fast or too slow, the feedback mechanism guides the user to adjust their technique during the same session. This ensures that the medication is delivered accurately, enhancing therapeutic outcomes and reducing the risk of treatment failure due to improper inhaler usage. Over time, this feedback helps patients build confidence in their inhaler technique, improving their overall adherence to the prescribed regimen.
In addition to monitoring inhalation, the device continuously evaluates environmental factors that may trigger asthma symptoms or exacerbate existing conditions. The environmental monitoring system, integrated with sensors, collects data on air quality, pollen levels, humidity, and temperature. These parameters are assessed in real time, and any potential risks are identified promptly. If the system detects poor air quality or high pollen levels, it transmits this information to the connected smartphone application, which notifies the user through alerts. These alerts enable the user to take preventive actions, such as staying indoors or using additional medication, to minimize the impact of environmental triggers. This proactive approach empowers users to manage their condition effectively, reducing the frequency and severity of asthma exacerbations.
The communication module within the device facilitates seamless data transfer to a smartphone application via IoT connectivity, such as Bluetooth or Wi-Fi. This ensures that all inhalation and environmental data are synchronized with the app in real time. The smartphone application serves as a central platform for viewing detailed logs of inhaler usage, environmental risk alerts, and adherence trends. Users can access this data at any time, gaining valuable insights into their asthma management. Healthcare providers can also remotely review the data, allowing them to assess the patient's adherence to treatment plans and make informed adjustments to the medication or management strategies. The ability to share data in real time enhances the collaboration between patients and healthcare providers, improving the overall quality of care.
The device's usage tracking system records every instance of inhaler usage, including the time, date, and frequency. This data is stored within the device and transmitted to the smartphone application for analysis. The system includes a memory module that retains historical data, enabling long-term tracking of adherence patterns. This feature is particularly beneficial for identifying trends and gaps in treatment, providing both patients and healthcare providers with a clear picture of how well the treatment plan is being followed. Non-adherence to prescribed medication regimens is a common challenge in asthma management, often leading to poor symptom control and increased healthcare costs. By addressing this issue, the usage tracking system ensures that patients stay on track with their treatment.
The smartphone application not only displays the data collected by the device but also provides personalized reminders and notifications. These reminders ensure that users take their medication on time and adhere to their inhaler usage schedule. Notifications about environmental risks, such as high pollen levels or poor air quality, further support the user in managing their condition proactively. The app also generates real-time analytics and trend reports, offering actionable insights that enhance patient education and self-management. For instance, the app may identify recurring environmental triggers that worsen the patient's symptoms, allowing them to take preventive measures in similar conditions. These insights help users better understand their condition and make informed decisions about their asthma management.
The compact and lightweight design of the device ensures that it is portable and easy to use. It can be attached to various types of inhalers without interfering with their functionality, making it suitable for a diverse patient population. The device's intuitive interface and user-friendly design make it accessible to individuals of all ages, including children and the elderly. Its energy-efficient power source supports extended periods of operation, reducing the need for frequent recharging and ensuring that the device remains functional throughout the day. This reliability is particularly important for users who require continuous monitoring in different environments.
During operation, the device seamlessly integrates its various components to provide a holistic solution for asthma management. The inhalation flow sensor works in tandem with the feedback mechanism to ensure proper inhaler usage, while the environmental monitoring system provides valuable insights into potential triggers. The communication module enables real-time data sharing with the smartphone application, which serves as a central hub for tracking, analyzing, and managing asthma-related data. This interconnected system reduces the burden on users, allowing them to focus on managing their condition without worrying about technical complexities.
The invention's ability to provide real-time feedback, environmental alerts, and comprehensive data tracking sets it apart as a valuable tool for asthma management. By combining advanced technologies with a user-friendly design, the device addresses the key challenges faced by asthma patients, including improper inhaler technique, non-adherence to treatment plans, and exposure to environmental triggers. Its innovative features and functionalities make it a powerful ally for both patients and healthcare providers, improving outcomes and enhancing the quality of life for individuals living with asthma.

Experimental validation of the invention: To validate the functionality and effectiveness of the asthma inhalation monitoring device (100), experimental studies were conducted to evaluate its performance across key parameters, including inhalation monitoring accuracy, feedback reliability, environmental sensing, and adherence tracking. The experiments were designed to simulate real-world scenarios involving asthma patients with varying levels of experience using inhalers.
In the first phase of validation, the inhalation flow sensor (10) was tested for its ability to measure the flow rate and volume of inhaler medication accurately. A controlled environment was set up using medical-grade inhaler simulators capable of replicating typical inhalation patterns observed in patients. The device was attached to the simulators, and a range of flow rates (10 to 60 liters per minute) and inhalation volumes (0.5 to 3 liters) were tested. The results showed that the device consistently measured flow rates with an accuracy of ±2% and inhalation volumes with an accuracy of ±5%. These results demonstrate the sensor's capability to detect and analyze inhalation parameters effectively, ensuring proper medication delivery.
The second phase focused on the real-time feedback mechanism (20). Patients were recruited and divided into two groups: those familiar with inhaler usage and those new to using inhalers. Each participant used the device during simulated inhaler sessions under controlled supervision. The feedback system provided visual (LED indicators) or audio (beeps or voice prompts) alerts when the inhalation technique was incorrect. Over 85% of participants in the new-user group successfully adjusted their technique within three sessions based on the feedback provided by the device. The experienced group demonstrated a 95% success rate in maintaining proper technique throughout the experiment. These findings validate the feedback mechanism's effectiveness in guiding users to achieve correct inhalation practices.
In the third phase, the environmental monitoring system (30) was evaluated for its accuracy and responsiveness in detecting potential asthma triggers. The sensors were exposed to controlled environments with varying air quality levels, pollen concentrations, humidity ranges, and temperatures. The results indicated that the system could accurately measure air quality with a ±3% deviation from standard air quality index sensors, detect pollen levels with a sensitivity of 90%, and monitor humidity and temperature within a ±2% margin of error. Alerts were generated in real-time and transmitted to the connected smartphone application, successfully notifying users of adverse environmental conditions in all test cases.
The communication module (40) was tested for data transfer reliability and latency. The device was paired with a smartphone application via Bluetooth and Wi-Fi in separate trials. Data on inhaler usage and environmental conditions were transmitted to the app, and the time taken for synchronization was recorded. The average synchronization time was 2.5 seconds for Bluetooth and 1.8 seconds for Wi-Fi. Additionally, the module maintained a stable connection with the app in 98% of trials conducted over a 24-hour period, demonstrating its robustness for real-time data sharing.
The usage tracking system (50) was validated by analyzing its ability to log inhaler usage accurately. Participants were instructed to use their inhalers at scheduled intervals over a seven-day period. The system recorded each usage event, including the time and date, with no missed entries. The recorded data was compared against manual logs maintained by the participants, and a 100% match was observed. This confirms the reliability of the usage tracking system in maintaining adherence records.
To assess the overall user experience, a survey was conducted among participants after using the device for two weeks. Over 90% of users reported that the device was easy to use and found the feedback mechanism and environmental alerts helpful for managing their asthma. Healthcare providers who reviewed the data logs through the smartphone application rated the system highly for its ability to provide actionable insights into patient adherence and symptom management.
The experimental results demonstrate that the asthma inhalation monitoring device performs reliably across all functional aspects. The inhalation flow sensor ensures precise monitoring of medication delivery, the feedback mechanism effectively guides users to correct their technique, and the environmental monitoring system provides timely alerts about potential asthma triggers. The communication module facilitates seamless data sharing, while the usage tracking system ensures accurate adherence logging. Collectively, these features validate the device's capability to enhance asthma management, providing both patients and healthcare providers with a robust tool for improving outcomes.

ADVANTAGES OF THE INVENTION:
The prime advantage of the invention is to provide precise monitoring of inhalation parameters, ensuring correct medication delivery and significantly improving therapeutic outcomes for asthma patients by reducing the likelihood of improper inhaler usage.
Another advantage of the invention is its real-time feedback mechanism, which alerts users about incorrect inhalation techniques, enabling immediate adjustments and fostering better adherence to treatment plans for enhanced symptom control.
Yet another advantage of the invention is its environmental monitoring system, which proactively detects asthma triggers such as poor air quality and high pollen levels, helping users avoid exacerbations and manage their condition effectively.
Still another advantage of the invention is the seamless integration with a smartphone application, allowing users to access detailed logs, personalized notifications, and adherence reports for better self-management and healthcare collaboration.
A further advantage of the invention is its compact and lightweight design, ensuring compatibility with various inhalers while maintaining portability, making it accessible to users across different age groups and physical abilities.
An additional advantage of the invention is its usage tracking system, which records and stores inhaler usage data accurately, helping users and healthcare providers identify adherence patterns and make informed treatment decisions.
Yet a further advantage of the invention is its energy-efficient design, enabling extended operation without frequent recharging, ensuring reliability and convenience for users who require continuous monitoring throughout the day.
Another advantage of the invention is its ability to generate real-time analytics and trend reports, empowering users with actionable insights to understand their condition and take preventive measures to improve long-term asthma control.
Still another advantage of the invention is the real-time data-sharing capability, enabling healthcare providers to remotely monitor patient adherence and environmental exposure, fostering timely intervention and personalized care.
A final advantage of the invention is its user-friendly interface, which simplifies operation for individuals with varying levels of technological proficiency, ensuring a seamless and stress-free experience for managing asthma effectively.
, Claims:CLAIM(S):
We Claim:
1. A device for asthma inhalation monitoring (100), comprising:
a. an inhalation flow sensor (10) configured to detect the flow rate and volume of medication intake during inhaler usage;
b. a feedback mechanism (20) providing real-time visual or audio cues to the user regarding inhalation technique;
c. an environmental monitoring system (30) equipped with sensors for detecting air quality, pollen levels, humidity, and temperature;
d. a communication module (40) enabling data transfer to a smartphone application via IoT connectivity;
e. a usage tracking system (50) recording the time, date, and frequency of inhaler usage for adherence monitoring.
2. The device of claim 1, wherein the inhalation flow sensor provides precise measurements of inhalation parameters to ensure proper medication delivery and improve treatment efficacy.
3. The device of claim 1, wherein the feedback mechanism alerts the user if the inhalation flow rate or duration is outside optimal ranges for effective medication delivery.
4. The device of claim 1, wherein the environmental monitoring system transmits trigger alerts to the user via a connected smartphone application.
5. The device of claim 1, wherein the communication module enables real-time sharing of usage and environmental data with healthcare providers for improved asthma management.
6. The device of claim 1, further comprising a smartphone application configured to display usage logs, environmental risk alerts, and adherence reports.
7. The device of claim 1, wherein the usage tracking system includes a memory module for storing historical data on medication adherence.
8. The device of claim 1, wherein the compact design ensures portability and ease of attachment to different inhaler models without obstructing functionality.
9. The device of claim 1, wherein the system provides reminders and notifications to the user for scheduled inhaler usage and potential environmental risks.
10. The device of claim 1, further configured to provide real-time analytics and trend reports through the smartphone application to enhance patient education and self-management.

Documents

NameDate
202411088808-COMPLETE SPECIFICATION [16-11-2024(online)].pdf16/11/2024
202411088808-DECLARATION OF INVENTORSHIP (FORM 5) [16-11-2024(online)].pdf16/11/2024
202411088808-DRAWINGS [16-11-2024(online)].pdf16/11/2024
202411088808-EDUCATIONAL INSTITUTION(S) [16-11-2024(online)].pdf16/11/2024
202411088808-EVIDENCE FOR REGISTRATION UNDER SSI [16-11-2024(online)].pdf16/11/2024
202411088808-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [16-11-2024(online)].pdf16/11/2024
202411088808-FIGURE OF ABSTRACT [16-11-2024(online)].pdf16/11/2024
202411088808-FORM 1 [16-11-2024(online)].pdf16/11/2024
202411088808-FORM FOR SMALL ENTITY(FORM-28) [16-11-2024(online)].pdf16/11/2024
202411088808-FORM-9 [16-11-2024(online)].pdf16/11/2024
202411088808-POWER OF AUTHORITY [16-11-2024(online)].pdf16/11/2024
202411088808-PROOF OF RIGHT [16-11-2024(online)].pdf16/11/2024
202411088808-REQUEST FOR EARLY PUBLICATION(FORM-9) [16-11-2024(online)].pdf16/11/2024

footer-service

By continuing past this page, you agree to our Terms of Service,Cookie PolicyPrivacy Policy  and  Refund Policy  © - Uber9 Business Process Services Private Limited. All rights reserved.

Uber9 Business Process Services Private Limited, CIN - U74900TN2014PTC098414, GSTIN - 33AABCU7650C1ZM, Registered Office Address - F-97, Newry Shreya Apartments Anna Nagar East, Chennai, Tamil Nadu 600102, India.

Please note that we are a facilitating platform enabling access to reliable professionals. We are not a law firm and do not provide legal services ourselves. The information on this website is for the purpose of knowledge only and should not be relied upon as legal advice or opinion.